T1	CHEM 109 116	ABT-493
#1	AnnotatorNotes T1	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T2	PROC 57 105	evaluar la eficacia, seguridad y farmacocinética
T3	CHEM 157 167	Ribavirina
#2	AnnotatorNotes T3	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T4	PROC 232 244	tratamientos
#3	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	PROC 284 328	Estudio aleatorizado, abierto, multicéntrico
T6	PROC 334 382	evaluar la eficacia, seguridad y farmacocinética
T7	CHEM 458 468	ribavirina
#4	AnnotatorNotes T7	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T8	DISO 485 530	infección crónica por virus de la hepatitis C
T9	PROC 559 570	tratamiento
#5	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	CHEM 582 611	antivirales de acción directa
#6	AnnotatorNotes T10	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T11	DISO 688 705	Virus Hepatitis C
T12	PROC 741 752	Tratamiento
#7	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	DISO 882 891	Infección
#8	AnnotatorNotes T13	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T14	PROC 929 940	tratamiento
#9	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	DISO 977 1002	Infección crónica por VHC
T16	CHEM 1173 1180	fármaco
#10	AnnotatorNotes T16	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T17	DISO 843 854	VHC crónico
T18	CHEM 409 416	ABT-493
#11	AnnotatorNotes T18	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T19	CHEM 1445 1452	fármaco
#12	AnnotatorNotes T19	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T20	CHEM 419 426	ABT-530
#13	AnnotatorNotes T20	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T21	DISO 1469 1480	alcoholismo
#14	AnnotatorNotes T21	C0001973; Alcoholic Intoxication, Chronic; Mental or Behavioral Dysfunction
T22	DISO 1483 1494	toxicomanía
#15	AnnotatorNotes T22	C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T23	PROC 1564 1573	protocolo
#16	AnnotatorNotes T23	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T24	PROC 1603 1666	análisis del antígeno de superficie del virus de la hepatitis B
#17	AnnotatorNotes T24	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T25	PROC 1668 1673	HbsAg
#18	AnnotatorNotes T25	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T26	PROC 1680 1738	anticuerpos contra el virus de la inmunodeficiencia humana
#19	AnnotatorNotes T26	C3714540; HIV Antibody Measurement; Laboratory Procedure
T27	PROC 1740 1751	Ac anti VIH
T28	CHEM 430 437	ABT-493
#20	AnnotatorNotes T28	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T29	DISO 1797 1800	VHC
#21	AnnotatorNotes T29	C0019196; Hepatitis C; Disease or Syndrome
T30	CHEM 119 126	ABT-530
#22	AnnotatorNotes T30	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T31	PROC 389 405	coadministración
T32	DISO 532 535	VHC
#23	AnnotatorNotes T32	C0019196; Hepatitis C; Disease or Syndrome
T33	PROC 767 774	régimen
#24	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	DISO 797 808	VHC crónica
T35	DISO 1023 1026	VHC
#25	AnnotatorNotes T35	C0019196; Hepatitis C; Disease or Syndrome
T36	CHEM 438 445	ABT-530
#26	AnnotatorNotes T36	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T37	PROC 1426 1452	administración del fármaco
#27	AnnotatorNotes T37	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T38	CHEM 1616 1666	antígeno de superficie del virus de la hepatitis B
T39	DISO 1093 1105	sensibilidad
T40	DISO 1757 1769	Co-infección
T41	CHEM 613 616	AAD
#28	AnnotatorNotes T41	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T42	CHEM 257 261	AADs
T43	DISO 194 205	VHC crónica
T44	CHEM 130 137	ABT-493
#29	AnnotatorNotes T44	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T45	CHEM 138 145	ABT-530
#30	AnnotatorNotes T45	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T46	DISO 707 710	VHC
#31	AnnotatorNotes T46	C0019196; Hepatitis C; Disease or Syndrome
T47	DISO 640 643	VHC
#32	AnnotatorNotes T47	C0019196; Hepatitis C; Disease or Syndrome
T48	CHEM 788 791	AAD
#33	AnnotatorNotes T48	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T49	Date 12 16	2015
T50	PHYS 90 105	farmacocinética
#34	AnnotatorNotes T50	C0031327; Drug Kinetics; Physiologic Function
T51	Neg_cue 153 156	sin
T52	LIVB 172 189	pacientes adultos
#35	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T54	LIVB 194 197	VHC
#36	AnnotatorNotes T54	C0220847; hepatitis C virus; Virus
T55	Duration 198 205	crónica
#37	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	PHYS 367 382	farmacocinética
#38	AnnotatorNotes T56	C0031327; Drug Kinetics; Physiologic Function
T57	Neg_cue 454 457	sin
T58	LIVB 473 480	adultos
#39	AnnotatorNotes T58	C0001675; Adult; Age Group
T59	Duration 495 502	crónica
#40	AnnotatorNotes T59	C0205191; chronic; Temporal Concept
T60	LIVB 507 530	virus de la hepatitis C
#41	AnnotatorNotes T60	C0220847; hepatitis C virus; Virus
T63	PROC 644 652	Genotipo
#42	AnnotatorNotes T63	C1285573; Genotype determination; Laboratory Procedure
T66	LIVB 797 800	VHC
#43	AnnotatorNotes T66	C0220847; hepatitis C virus; Virus
T67	Duration 801 808	crónica
#44	AnnotatorNotes T67	C0205191; chronic; Temporal Concept
T69	LIVB 843 846	VHC
#45	AnnotatorNotes T69	C0220847; hepatitis C virus; Virus
T70	Duration 847 854	crónico
#46	AnnotatorNotes T70	C0205191; chronic; Temporal Concept
T71	PROC 855 864	genotipos
#47	AnnotatorNotes T71	C1285573; Genotype determination; Laboratory Procedure
T72	Date 958 972	postratamiento
T73	Duration 987 994	crónica
#48	AnnotatorNotes T73	C0205191; chronic; Temporal Concept
T74	LIVB 999 1002	VHC
#49	AnnotatorNotes T74	C0220847; hepatitis C virus; Virus
T75	PROC 810 818	genotipo
#50	AnnotatorNotes T75	C1285573; Genotype determination; Laboratory Procedure
T77	Spec_cue 1113 1127	potencialmente
T78	DISO 1128 1134	mortal
#51	AnnotatorNotes T78	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T79	LIVB 1185 1204	Mujeres embarazadas
#52	AnnotatorNotes T79	C0033011; Pregnant Women; Population Group
T80	LIVB 1299 1305	pareja
#53	AnnotatorNotes T80	C0682323; Partner in relationship; Family Group
T81	Duration 1401 1412	los 6 meses
T82	LIVB 1515 1527	investigador
#54	AnnotatorNotes T82	C0035173; Research Personnel; Professional or Occupational Group
T85	LIVB 1643 1666	virus de la hepatitis B
#55	AnnotatorNotes T85	C0019169; hepatitis B virus; Virus
T86	LIVB 1702 1738	virus de la inmunodeficiencia humana
#56	AnnotatorNotes T86	C0019682; HIV; Virus
T87	LIVB 1748 1751	VIH
#57	AnnotatorNotes T87	C0019682; HIV; Virus
T88	PROC 1784 1792	genotipo
#58	AnnotatorNotes T88	C1285573; Genotype determination; Laboratory Procedure
T90	PHYS 1227 1238	embarazadas
#59	AnnotatorNotes T90	C0032961; Pregnancy; Organism Function
T91	PHYS 1311 1321	embarazada
#60	AnnotatorNotes T91	C0032961; Pregnancy; Organism Function
T92	PHYS 1340 1350	embarazada
#61	AnnotatorNotes T92	C0032961; Pregnancy; Organism Function
T53	PHYS 1193 1204	embarazadas
#62	AnnotatorNotes T53	C0032961; Pregnancy; Organism Function
T61	PHYS 1274 1283	lactancia
#63	AnnotatorNotes T61	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T62	LIVB 1286 1293	varones
#64	AnnotatorNotes T62	C0025266; Male population group; Population Group
T64	DISO 947 954	recaída
#65	AnnotatorNotes T64	C2825055; Recurrence (disease attribute); Pathologic Function
T65	LIVB 1185 1192;1260 1283	Mujeres en período de lactancia
#66	AnnotatorNotes T65	C4316174; Patients who are breastfeeding; Patient or Disabled Group
A1	Assertion T3 Negated
A2	Population_data T52 Age
A3	Assertion T7 Negated
A4	Population_data T58 Age
A5	Assertion T78 Speculated
A6	Status T4 History_of
A7	Status T42 History_of
A8	Status T10 History_of
A9	Status T41 History_of
A10	Status T9 History_of
A11	Status T12 History_of
A12	Status T33 History_of
A13	Status T48 History_of
A14	Status T39 History_of
A15	Status T21 History_of
A16	Status T22 History_of
#67	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity + C0201734; Pharmacokinetic study; Research Activity
#68	AnnotatorNotes T43	C0524910; Hepatitis C, Chronic; Disease or Syndrome 
#69	AnnotatorNotes T5	C0034656; Randomization; Research Activity + C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity
#70	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity + C0201734; Pharmacokinetic study; Research Activity
#71	AnnotatorNotes T8	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#72	AnnotatorNotes T11	C0019196; Hepatitis C; Disease or Syndrome
#73	AnnotatorNotes T34	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#74	AnnotatorNotes T17	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#75	AnnotatorNotes T39	C0020517; Hypersensitivity; Pathologic Function | C1527304; Allergic Reaction; Pathologic Function
#76	AnnotatorNotes T27	C3714540; HIV Antibody Measurement; Laboratory Procedure
#77	AnnotatorNotes T40	C0275524; Coinfection; Disease or Syndrome 
T68	Neg_cue 1536 1543	impedir
T76	Observation 1547 1573	cumplimiento del protocolo
A17	Assertion T76 Negated
R1	Negation Arg1:T51 Arg2:T3	
R2	Negation Arg1:T57 Arg2:T7	
R3	Speculation Arg1:T77 Arg2:T78	
T83	Quantifier_or_Qualifier 1137 1147	importante
A18	Assertion T83 Speculated
R4	Speculation Arg1:T77 Arg2:T83	
R5	Negation Arg1:T68 Arg2:T76	
#78	AnnotatorNotes T76	C2364172; Adherence To Medication Regime; Finding (?)
R6	Combined_with Arg1:T44 Arg2:T45	
R7	Combined_with Arg1:T1 Arg2:T3	
R8	Combined_with Arg1:T30 Arg2:T3	
R9	Combined_with Arg1:T44 Arg2:T3	
R10	Combined_with Arg1:T18 Arg2:T7	
R11	Combined_with Arg1:T20 Arg2:T7	
R12	Combined_with Arg1:T28 Arg2:T36	
R13	Combined_with Arg1:T28 Arg2:T7	
R14	Causes Arg1:T54 Arg2:T43	
R15	Has_Duration_or_Interval Arg1:T43 Arg2:T55	
R16	Experiences Arg1:T52 Arg2:T50	
R17	Experiences Arg1:T52 Arg2:T1	
R18	Experiences Arg1:T52 Arg2:T30	
R19	Experiences Arg1:T52 Arg2:T44	
R20	Experiences Arg1:T52 Arg2:T3	
R21	Experiences Arg1:T52 Arg2:T43	
R22	Experiences Arg1:T52 Arg2:T4	
R23	Used_for Arg1:T42 Arg2:T4	
T84	Observation 216 223	fallado
R24	Before Arg1:T4 Arg2:T84	
R25	Experiences Arg1:T52 Arg2:T84	
A19	Status T84 History_of
#79	AnnotatorNotes T42	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
#80	AnnotatorNotes T31	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure (?)
R26	Used_for Arg1:T18 Arg2:T31	
R27	Used_for Arg1:T20 Arg2:T31	
R28	Used_for Arg1:T28 Arg2:T31	
R29	Experiences Arg1:T58 Arg2:T56	
R30	Experiences Arg1:T58 Arg2:T31	
R31	Experiences Arg1:T58 Arg2:T8	
R32	Experiences Arg1:T58 Arg2:T32	
R33	Causes Arg1:T60 Arg2:T8	
R34	Has_Duration_or_Interval Arg1:T8 Arg2:T59	
R35	Has_Duration_or_Interval Arg1:T32 Arg2:T59	
T89	Observation 548 555	fracasó
R36	Before Arg1:T9 Arg2:T89	
R37	Used_for Arg1:T10 Arg2:T9	
R38	Used_for Arg1:T41 Arg2:T9	
R39	Experiences Arg1:T58 Arg2:T89	
R40	Experiences Arg1:T58 Arg2:T9	
R41	Causes Arg1:T60 Arg2:T32	
T93	Quantifier_or_Qualifier 644 662	Genotipo 1 o 4,5,6
R42	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T93	
R44	Used_for Arg1:T48 Arg2:T12	
R45	Causes Arg1:T66 Arg2:T34	
R46	Has_Duration_or_Interval Arg1:T34 Arg2:T67	
T94	Quantifier_or_Qualifier 810 820	genotipo 1
R48	Causes Arg1:T69 Arg2:T17	
R49	Has_Duration_or_Interval Arg1:T17 Arg2:T70	
T95	Quantifier_or_Qualifier 855 870	genotipos 4,5,6
R47	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T94	
R52	Has_Quantifier_or_Qualifier Arg1:T69 Arg2:T95	
T96	Observation 909 925	fallo virológico
#81	AnnotatorNotes T96	C4053865; Virologic Non-Response; Finding (?)
R53	Before Arg1:T14 Arg2:T96	
R54	Causes Arg1:T96 Arg2:T13	
R55	Causes Arg1:T64 Arg2:T13	
R56	Overlap Arg1:T64 Arg2:T72	
T97	Quantifier_or_Qualifier 1003 1006	GT1
R58	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T97	
R59	Has_Duration_or_Interval Arg1:T15 Arg2:T73	
#82	AnnotatorNotes T15	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T98	Quantifier_or_Qualifier 1027 1035	G1 o 4-6
R60	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T98	
R61	Before Arg1:T39 Arg2:T78	
R62	Causes Arg1:T16 Arg2:T39	
#83	AnnotatorNotes T83	C3898777; Important; Qualitative Concept
T99	Quantifier_or_Qualifier 1106 1111	grave
#84	AnnotatorNotes T99	C1547227; Severe - Severity of Illness Code; Intellectual Product
R63	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T99	
A20	Status T99 History_of
R64	Experiences Arg1:T79 Arg2:T53	
T100	Observation 1210 1238	planeen quedarse embarazadas
#85	AnnotatorNotes T100	C0032992; Pregnancy, Planned; Finding
R65	Before Arg1:T100 Arg2:T90	
R66	Experiences Arg1:T65 Arg2:T61	
T101	PROC 1250 1257	estudio
#86	AnnotatorNotes T101	C0008976; Clinical Trials; Research Activity
R68	Overlap Arg1:T100 Arg2:T101	
R69	Overlap Arg1:T90 Arg2:T101	
R70	Overlap Arg1:T101 Arg2:T61	
R71	Overlap Arg1:T101 Arg2:T91	
R72	Overlap Arg1:T101 Arg2:T92	
T102	PROC 1362 1369	estudio
#87	AnnotatorNotes T102	C0008976; Clinical Trials; Research Activity
T103	Observation 1324 1350	planee quedarse embarazada
#88	AnnotatorNotes T103	C0032992; Pregnancy, Planned; Finding
R73	Before Arg1:T103 Arg2:T92	
R74	Overlap Arg1:T103 Arg2:T102	
R75	Overlap Arg1:T92 Arg2:T102	
R76	Overlap Arg1:T61 Arg2:T102	
R77	Overlap Arg1:T91 Arg2:T102	
R78	Overlap Arg1:T53 Arg2:T102	
R79	Overlap Arg1:T100 Arg2:T102	
R80	Experiences Arg1:T80 Arg2:T91	
R81	Experiences Arg1:T80 Arg2:T92	
R82	Overlap Arg1:T21 Arg2:T81	
R83	Overlap Arg1:T22 Arg2:T81	
R84	Before Arg1:T21 Arg2:T37	
R85	Before Arg1:T22 Arg2:T37	
R86	Used_for Arg1:T19 Arg2:T37	
R87	Before Arg1:T21 Arg2:T76	
R88	Before Arg1:T22 Arg2:T76	
T104	Result_or_Value 1578 1596	Resultado positivo
#89	AnnotatorNotes T104	C1446409; Positive; Finding
R89	Has_Result_or_Value Arg1:T24 Arg2:T104	
R90	Has_Result_or_Value Arg1:T25 Arg2:T104	
R91	Has_Result_or_Value Arg1:T26 Arg2:T104	
R92	Has_Result_or_Value Arg1:T27 Arg2:T104	
R93	Causes Arg1:T85 Arg2:T104	
R94	Causes Arg1:T86 Arg2:T104	
R95	Causes Arg1:T87 Arg2:T104	
#90	AnnotatorNotes T38	C0369334; Hepatitis B Virus Surface Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor
R98	Overlap Arg1:T40 Arg2:T29	
T105	Quantifier_or_Qualifier 1774 1792	más de un genotipo
R97	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T105	
#91	AnnotatorNotes T84	C0162643; treatment failure; Finding
#92	AnnotatorNotes T89	C0162643; treatment failure; Finding
R43	Overlap Arg1:T53 Arg2:T101	
A21	Experiencer T52 Patient
A22	Experiencer T58 Patient
A23	Status T90 Future
A24	Experiencer T65 Patient
A25	Experiencer T79 Patient
A26	Experiencer T62 Patient
A27	Experiencer T80 Family_member
A28	Status T92 Future
A29	Experiencer T82 Other
